NVLX, an international biotechnology company provi
Post# of 63700
Posted On: 01/27/2014 8:36:18 AM
NVLX, an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that Dr. Walter H. Gunzburg, Chairman and Chief Technical Officer of Nuvilex's partner Austrianova, will present at the international Phacilitate Cell & Gene Therapy Forum 2014 to be held in Washington, DC January 27-29, 2014. Dr. Gunzburg is the co-developer of the novel proprietary and patented cell encapsulation technology that Nuvilex expects will have a profound effect on how cancers and diabetes will be treated in the future.
(0)
(0)Scroll down for more posts ▼